IF you do signal transduction, oncology
or other preclinical research,

THEN you have probably been relying on
LC Labs products, directly or indirectly,
from the time you started your research
(unless you started more than ~28 years ago)

In Business for 29 Years - Since 1980, manufacturing and selling directly and
through dozens of distributors, LC Laboratories has provided the biomedical
research community with some of its most important small-molecule reagents.

Even if you just found our website or catalog yesterday, you have probably used
one or many of our top-quality, widely-used products over the years, via purchases
from our numerous distributors under their labels (some of these firms have merged
or been acquired):

Consider the ultimate level of customer testimonials, namely, the enduring confidence
in LC Labs that our distributors — large, famous, highly reputable firms respected the
world over — have demonstrated by buying and reselling many hundreds of thousands
of vials' worth of our products under their labels during the past 29 years:

Relying on tens of thousands of publications:  not only might you have used LC
Labs' products for many years yourself, you have also undoubtedly relied on data
reported in the tens of thousands of publications that used our products, purchased
directly from us or under our distributors' labels, during the past 29 years.

An unparalleled record of innovation for
major signal transduction reagents:

1980 - LC Labs becomes the primary worldwide source of PMA (phorbol 12-myristate
13-acetate; TPA), and this has continued uninterrupted for 29 years — more than
150,000 vials sold

1989 - LC Labs provides the first high-purity, low-cost Thapsigargin to the research
market

1990 - first high-purity, low-cost Okadaic Acid

1991 - first high-purity, low-cost Calyculin A — and we remain the primary worldwide
source for this widely-used phosphatase inhibitor

1995 - first isomerically pure, low-cost Gö 6976

1996 - first high-purity, low-cost Bafilomycin A1

2002 - first high-purity, low-cost Rapamycin

2002 - first high-purity, low-cost FK-506

2003 - first high-purity, low-cost Leptomycin B

2004 - first high-purity, low-cost Staurosporine

2004 - first high-purity, low-cost Cyclopamine

2007 - LC Labs introduces the first group of high-purity, low-cost major Protein Kinase
Inhibitors for prelinical oncology and related research

Back to top

Home

Quick Product Lists

Contact LC Labs

View Cart